Golden
LabGenius

LabGenius

Synthetic biology company that combines AI, DNA synthesis, and robotics to discover biological molecules.

LabGenius is a privately held, synthetic biology company based in London, UK. It uses a combination of artificial intelligence, DNA synthesis, and robotics to discover high-value biological molecules.



The company's novel technology is able to produce trillions of variations of gene sequences, which can be used to create new biological materials using artificial intelligence. It can predict which gene mutations will improve a biological design, thereby enabling scientists to produce new therapeutics or other materials such as adhesives, catalysts, and sensors.



LabGenius, in partnership with leading multinationals, is developing various products, focusing on the areas of biotherapeutics, advanced materials, and personal care. In the biotherapeutics category, LabGenius' AI-driven evolution engine, EVA, is learning how to optimally enhance the stability of therapeutic proteins in protease rich environments such as the GI tract, tumor microenvironments, and inflammed tissues. The end goal is to enable the delivery of novel therapies for unmet clinical needs.



In the advanced materials area, engineered proteins can be used to form high value coatings, adhesives, fibres, catalysts, and sensors. LabGenius has completed several development projects in this area and are engaged in collaborative development with aerospace and defence companies.

Timeline

People

Name
Role
Related Golden topics

Dr. Adam Tomassi-Russel

Chief Commercial Officer



Dr. Annelie Oswald

Platform Scientist



Dr. Ben Mackrow

Synthetic Biologist



Dr. Chris Cozens

Molecular Biologist



Dr. Eyal Kazin

Data Scientist



Dr. Fiona Rowan

Biologics Scientist



Dr. Katya Putintseva

Data Scientist



Dr. Maria Bagniewska

Program Manager



Dr. Pedro Tizei

Automation Scientist



Dr. Pierre-Yves Colin

Molecular Biologist



Dr. Richard Menzies-Wilson

Operations Manager



Eddie Li

Full Stack Developer



George Morriss

Employee



Harry Rickerby

CSO



James Field

Founder & CEO



Leila Zegna

Investor Director



Mo Niknafs

Head of Non-Dilutive Financing



Oli Hall

Employee



Philipp Moehring

Investor



Staffan Piledahl

Software Engineer



Further reading

Title
Author
Link
Type
Date

LabGenius Locks Down $3.66m From Top-Tier Investors To Harness Evolution - SynBioBeta



Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References